GenScript Raises $1 Billion in Investments from Hillhouse Capital
May 14, 2021 at 05:38 AM EDT
GenScript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to GenScript's Legend Biotech CAR-T subsidiary. Before the investments, GenScript had a market capitalization of $6 billion and Legend was worth $4 billion. GenScript's original business unit, the Life Science Group, (now one of four businesses) offers proprietary gene synthesis technology to researchers with a global market share of 30%. More details.... Stock Symbols: (HK: 1548) (NSDQ: LEGN) Share this with colleagues: // //